Megiddo Dalia 4
4 · Foamix Pharmaceuticals Ltd. · Filed May 10, 2018
Insider Transaction Report
Form 4
Megiddo Dalia
Director
Transactions
- Award
Options
2018-05-08+24,883→ 24,883 totalExercise: $5.02Exp: 2028-05-08→ Ordinary Shares (24,883 underlying)
Footnotes (2)
- [F1]Each option represents a contingent right to purchase one ordinary share of the issuer.
- [F2]The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 8, 2019.